{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:34:38Z","timestamp":1787020478610,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"lung foundation netherlands","award":["6.2.15.044JO"],"award-info":[{"award-number":["6.2.15.044JO"]}]},{"DOI":"10.13039\/501100003958","name":"stichting voor de technische wetenschappen","doi-asserted-by":"publisher","award":["NWO-STW Perspectief program P12-04"],"award-info":[{"award-number":["NWO-STW Perspectief program P12-04"]}],"id":[{"id":"10.13039\/501100003958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a strong need for biomarkers to better characterize individuals with COPD and to take into account the heterogeneity of COPD. The blood protein sRAGE has been put forward as promising biomarker for COPD in general and emphysema in particular. Here, we measured plasma sRAGE levels using quantitative LC\u2013MS and assessed whether the plasma sRAGE levels associate with (changes in) lung function, radiological emphysema parameters, and radiological subtypes of emphysema.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Three hundred and twenty-four COPD patients (mean FEV\n                      <jats:sub>1<\/jats:sub>\n                      : 63%predicted) and 185 healthy controls from the COPDGene study were selected. Plasma sRAGE was measured by immunoprecipitation in 96-well plate methodology to enrich sRAGE, followed by targeted quantitative liquid chromatography-mass spectrometry. Spirometry and HRCT scans (inspiration and expiration) with a 5-year follow-up were used; both subjected to high quality control standards.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Lower sRAGE values significantly associated with the presence of COPD, the severity of airflow obstruction, the severity of emphysema on HRCT, the heterogeneous distribution of emphysema, centrilobular emphysema, and 5-year progression of emphysema. However, sRAGE values did not associate with airway wall thickness or paraseptal emphysema.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Rather than being a general COPD biomarker, sRAGE is especially a promising biomarker for centrilobular emphysema. Follow-up studies should elucidate whether sRAGE can be used as a biomarker for other COPD phenotypes as well.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-022-01934-w","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:02:37Z","timestamp":1642982557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans"],"prefix":"10.1186","volume":"23","author":[{"given":"Frank","family":"Klont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Horvatovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell P.","family":"Bowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"van Rikxoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick H. T.","family":"ten Hacken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7345-8061","authenticated-orcid":false,"given":"Simon D.","family":"Pouwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"1934_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40291-019-00413-1","volume":"23","author":"M Cazzola","year":"2019","unstructured":"Cazzola M, Puxeddu E, Ora J, Rogliani P. Evolving concepts in chronic obstructive pulmonary disease blood-based biomarkers. Mol Diagn Ther. 2019;23:603\u201314.","journal-title":"Mol Diagn Ther"},{"key":"1934_CR2","doi-asserted-by":"publisher","first-page":"e000431","DOI":"10.1136\/bmjresp-2019-000431","volume":"6","author":"BR Celli","year":"2019","unstructured":"Celli BR, Anderson JA, Brook R, Calverley P, Cowans NJ, Crim C, et al. Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial. BMJ Open Respir Res. 2019;6:e000431.","journal-title":"BMJ Open Respir Res"},{"key":"1934_CR3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/thoraxjnl-2013-204778","volume":"69","author":"R Faner","year":"2014","unstructured":"Faner R, Tal-Singer R, Riley JH, Celli B, Vestbo J, MacNee W, et al. Lessons from ECLIPSE: a review of COPD biomarkers. Thorax (England). 2014;69:666\u201372.","journal-title":"Thorax (England)"},{"key":"1934_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12931-021-01686-z","volume":"22","author":"KA Pratte","year":"2021","unstructured":"Pratte KA, Curtis JL, Kechris K, Couper D, Cho MH, Silverman EK, et al. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD. Respir Res. 2021;22:127.","journal-title":"Respir Res"},{"key":"1934_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12931-017-0597-7","volume":"18","author":"RL Zemans","year":"2017","unstructured":"Zemans RL, Jacobson S, Keene J, Kechris K, Miller BE, Tal-Singer R, et al. Multiple biomarkers predict disease severity, progression and mortality in COPD. Respir Res. 2017;18:117.","journal-title":"Respir Res"},{"key":"1934_CR6","doi-asserted-by":"publisher","first-page":"35507","DOI":"10.1074\/jbc.M806948200","volume":"283","author":"L Zhang","year":"2008","unstructured":"Zhang L, Bukulin M, Kojro E, Roth A, Metz VV, Fahrenholz F, et al. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem. 2008;283:35507\u201316.","journal-title":"J Biol Chem"},{"key":"1934_CR7","doi-asserted-by":"publisher","first-page":"23137","DOI":"10.1074\/jbc.M110.133827","volume":"285","author":"H Zong","year":"2010","unstructured":"Zong H, Madden A, Ward M, Mooney MH, Elliott CT, Stitt AW. Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction. J Biol Chem. 2010;285:23137\u201346.","journal-title":"J Biol Chem"},{"key":"1934_CR8","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3389\/fphar.2018.00684","volume":"9","author":"H Lee","year":"2018","unstructured":"Lee H, Lee J, Hong S-H, Rahman I, Yang S-R. Inhibition of RAGE attenuates cigarette smoke-induced lung epithelial cell damage via RAGE-mediated Nrf2\/DAMP signaling. Front Pharmacol. 2018;9:684.","journal-title":"Front Pharmacol"},{"key":"1934_CR9","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1096\/fj.201601155R","volume":"31","author":"H Lee","year":"2017","unstructured":"Lee H, Park J-R, Kim WJ, Sundar IK, Rahman I, Park S-M, et al. Blockade of RAGE ameliorates elastase-induced emphysema development and progression via RAGE-DAMP signaling. FASEB J. 2017;31:2076\u201389.","journal-title":"FASEB J"},{"issue":"4","key":"1934_CR10","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/all.14563","volume":"76","author":"VSRR Allam","year":"2020","unstructured":"Allam VSRR, Faiz A, Lam M, Rathnayake SNH, Ditz B, Pouwels SD, et al. RAGE and TLR4 differentially regulate airway hyperresponsiveness: Implications for COPD. Allergy. 2020;76(4):1123\u201335.","journal-title":"Allergy"},{"key":"1934_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.intimp.2017.06.018","volume":"50","author":"M Chen","year":"2017","unstructured":"Chen M, Wang T, Shen Y, Xu D, Li X, An J, et al. Knockout of RAGE ameliorates mainstream cigarette smoke-induced airway inflammation in mice. Int Immunopharmacol. 2017;50:230\u20135.","journal-title":"Int Immunopharmacol"},{"key":"1934_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1183\/23120541.00947-2020","volume":"7","author":"A Faiz","year":"2021","unstructured":"Faiz A, Rathnayake SNH, Ten Hacken NHT, Guryev V, van den Berge M, Pouwels SD. Single-nucleotide polymorphism rs2070600 regulates AGER splicing and the sputum levels of the COPD biomarker soluble receptor for advanced glycation end-products. ERJ Open Res. 2021;7:2.","journal-title":"ERJ Open Res."},{"key":"1934_CR13","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1164\/rccm.201302-0247OC","volume":"188","author":"DT Cheng","year":"2013","unstructured":"Cheng DT, Kim DK, Cockayne DA, Belousov A, Bitter H, Cho MH, et al. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188:948\u201357.","journal-title":"Am J Respir Crit Care Med"},{"key":"1934_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1183\/09031936.00135312","volume":"43","author":"P Gopal","year":"2014","unstructured":"Gopal P, Reynaert NL, Scheijen JLJM, Engelen L, Schalkwijk CG, Franssen FME, et al. Plasma advanced glycation end-products and skin autofluorescence are increased in COPD. Eur Respir J. 2014;43:430\u20138.","journal-title":"Eur Respir J"},{"key":"1934_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12931-016-0363-2","volume":"17","author":"SJM Hoonhorst","year":"2016","unstructured":"Hoonhorst SJM, Lo Tam Loi AT, Pouwels SD, Faiz A, Telenga ED, et al. Advanced glycation endproducts and their receptor in different body compartments in COPD. Respir Res. 2016;17:46.","journal-title":"Respir Res"},{"key":"1934_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1471-2466-14-68","volume":"14","author":"H Iwamoto","year":"2014","unstructured":"Iwamoto H, Gao J, Pulkkinen V, Toljamo T, Nieminen P, Mazur W. Soluble receptor for advanced glycation end-products and progression of airway disease. BMC Pulm Med. 2014;14:68.","journal-title":"BMC Pulm Med"},{"key":"1934_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1183\/09031936.00029310","volume":"37","author":"DJ Smith","year":"2011","unstructured":"Smith DJ, Yerkovich ST, Towers MA, Carroll ML, Thomas R, Upham JW. Reduced soluble receptor for advanced glycation end-products in COPD. Eur Respir J. 2011;37:516\u201322.","journal-title":"Eur Respir J"},{"key":"1934_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1183\/09031936.00022011","volume":"39","author":"MB Sukkar","year":"2012","unstructured":"Sukkar MB, Wood LG, Tooze M, Simpson JL, McDonald VM, Gibson PG, et al. Soluble RAGE is deficient in neutrophilic asthma and COPD. Eur Respir J. 2012;39:721\u20139.","journal-title":"Eur Respir J"},{"key":"1934_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1164\/rccm.201501-0137PP","volume":"192","author":"JG Yonchuk","year":"2015","unstructured":"Yonchuk JG, Silverman EK, Bowler RP, Agust\u00ed A, Lomas DA, Miller BE, et al. Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung. Am J Respir Crit Care Med. 2015;192:785\u201392.","journal-title":"Am J Respir Crit Care Med"},{"key":"1934_CR20","doi-asserted-by":"publisher","first-page":"e38629","DOI":"10.1371\/journal.pone.0038629","volume":"7","author":"DA Cockayne","year":"2012","unstructured":"Cockayne DA, Cheng DT, Waschki B, Sridhar S, Ravindran P, Hilton H, et al. Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity. PLoS ONE. 2012;7:e38629.","journal-title":"PLoS ONE"},{"key":"1934_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1465-9921-12-37","volume":"12","author":"M Miniati","year":"2011","unstructured":"Miniati M, Monti S, Basta G, Cocci F, Fornai E, Bottai M. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respir Res. 2011;12:37.","journal-title":"Respir Res"},{"key":"1934_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12931-014-0127-9","volume":"15","author":"BJ Carolan","year":"2014","unstructured":"Carolan BJ, Hughes G, Morrow J, Hersh CP, O\u2019Neal WK, Rennard S, et al. The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes. Respir Res. 2014;15:127.","journal-title":"Respir Res"},{"key":"1934_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(13)70006-7","volume":"1","author":"HO Coxson","year":"2013","unstructured":"Coxson HO, Dirksen A, Edwards LD, Yates JC, Agusti A, Bakke P, et al. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med. 2013;1:129\u201336.","journal-title":"Lancet Respir Med"},{"key":"1934_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.talanta.2018.02.015","volume":"182","author":"F Klont","year":"2018","unstructured":"Klont F, Pouwels SD, Hermans J, van de Merbel NC, Horvatovich P, Ten Hacken NHT, et al. A fully validated liquid chromatography-mass spectrometry method for the quantification of the soluble receptor of advanced glycation end-products (sRAGE) in serum using immunopurification in a 96-well plate format. Talanta. 2018;182:414\u201321.","journal-title":"Talanta"},{"key":"1934_CR25","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1164\/rccm.201807-1249LE","volume":"198","author":"SD Pouwels","year":"2018","unstructured":"Pouwels SD, Klont F, Kwiatkowski M, Wiersma VR, Faiz A, van den Berge M, et al. Cigarette smoking acutely decreases serum levels of the chronic obstructive pulmonary disease biomarker sRAGE. Am J Respir Crit Care Med. 2018;198:1456\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"1934_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/15412550903499522","volume":"7","author":"EA Regan","year":"2010","unstructured":"Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7:32\u201343.","journal-title":"COPD"},{"key":"1934_CR27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1001\/jamainternmed.2015.2735","volume":"175","author":"EA Regan","year":"2015","unstructured":"Regan EA, Lynch DA, Curran-Everett D, Curtis JL, Austin JHM, Grenier PA, et al. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med. 2015;175:1539\u201349.","journal-title":"JAMA Intern Med"},{"key":"1934_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1148\/radiol.2015141579","volume":"277","author":"DA Lynch","year":"2015","unstructured":"Lynch DA, Austin JHM, Hogg JC, Grenier PA, Kauczor H-U, Bankier AA, et al. CT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner Society. Radiology. 2015;277:192\u2013205.","journal-title":"Radiology"},{"key":"1934_CR29","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.rmed.2007.04.016","volume":"101","author":"J Stolk","year":"2007","unstructured":"Stolk J, Putter H, Bakker EM, Shaker SB, Parr DG, Piitulainen E, et al. Progression parameters for emphysema: a clinical investigation. Respir Med (England). 2007;101:1924\u201330.","journal-title":"Respir Med (England)"},{"key":"1934_CR30","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1513\/AnnalsATS.201802-150OC","volume":"15","author":"LM Paulin","year":"2018","unstructured":"Paulin LM, Smith BM, Koch A, Han M, Hoffman EA, Martinez C, et al. Occupational exposures and computed tomographic imaging characteristics in the SPIROMICS Cohort. Ann Am Thorac Soc. 2018;15:1411\u20139.","journal-title":"Ann Am Thorac Soc"},{"key":"1934_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1513\/AnnalsATS.201806-424OC","volume":"16","author":"ER Miller","year":"2019","unstructured":"Miller ER, Putman RK, Diaz AA, Xu H, San Jos\u00e9 Est\u00e9par R, Araki T, et al. Increased airway wall thickness in interstitial lung abnormalities and idiopathic pulmonary fibrosis. Ann Am Thorac Soc. 2019;16:447\u201354.","journal-title":"Ann Am Thorac Soc"},{"key":"1934_CR32","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1164\/rccm.201411-2105LE","volume":"191","author":"E Pompe","year":"2015","unstructured":"Pompe E, van Rikxoort EM, Schmidt M, R\u00fchaak J, Estrella LG, Vliegenthart R, et al. Parametric response mapping adds value to current computed tomography biomarkers in diagnosing chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191:1084\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"1934_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1164\/rccm.201807-1351SO","volume":"199","author":"SP Bhatt","year":"2019","unstructured":"Bhatt SP, Washko GR, Hoffman EA, Newell JDJ, Bodduluri S, Diaz AA, et al. Imaging advances in chronic obstructive pulmonary disease. Insights from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) Study. Am J Respir Crit Care Med. 2019;199:286\u2013301.","journal-title":"Am J Respir Crit Care Med"},{"key":"1934_CR34","doi-asserted-by":"publisher","first-page":"W460","DOI":"10.2214\/AJR.12.10102","volume":"201","author":"JD Schroeder","year":"2013","unstructured":"Schroeder JD, McKenzie AS, Zach JA, Wilson CG, Curran-Everett D, Stinson DS, et al. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. AJR Am J Roentgenol. 2013;201:W460\u201370.","journal-title":"AJR Am J Roentgenol"},{"key":"1934_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/1874306401206010155","volume":"6","author":"M Takahashi","year":"2012","unstructured":"Takahashi M, Yamada G, Koba H, Takahashi H. Classification of centrilobular emphysema based on CT-pathologic correlations. Open Respir Med J. 2012;6:155\u20139.","journal-title":"Open Respir Med J"},{"key":"1934_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1465-9921-15-52","volume":"15","author":"V Kim","year":"2014","unstructured":"Kim V, Davey A, Comellas AP, Han MK, Washko G, Martinez CH, et al. Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res. 2014;15:52.","journal-title":"Respir Res"},{"key":"1934_CR37","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/resp.12505","volume":"20","author":"TN Van","year":"2015","unstructured":"Van TN, Ryujin Y, Ogawa E, Trang LTH, Kanda R, Goto K, et al. Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: consistent results from two cohorts. Respirology (Carlton, VIC). 2015;20:594\u2013601.","journal-title":"Respirology (Carlton, VIC)"},{"key":"1934_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.rmed.2013.08.014","volume":"108","author":"FAA Mohamed Hoesein","year":"2014","unstructured":"Mohamed Hoesein FAA, Schmidt M, Mets OM, Gietema HA, Lammers J-WJ, Zanen P, et al. Discriminating dominant computed tomography phenotypes in smokers without or with mild COPD. Respir Med. 2014;108:136\u201343.","journal-title":"Respir Med"},{"issue":"6","key":"1934_CR39","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1164\/rccm.201812-2257LE","volume":"199","author":"SD Pouwels","year":"2019","unstructured":"Pouwels SD, Klont F, Kwiatkowski M, Wiersma VR, Faiz A, van den Berge M, et al. Reply to biswas: acute and chronic effects of cigarette smoking on sRAGE. Am J Respir Crit Care Med. 2019;199(6):806\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"1934_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1165\/rcmb.2013-0013OC","volume":"49","author":"MP Stogsdill","year":"2013","unstructured":"Stogsdill MP, Stogsdill J, Bodine BG, Fredrickson AC, Sefcik TL, Wood TT, et al. Conditional overexpression of receptors for advanced glycation end-products in the adult murine lung causes airspace enlargement and induces inflammation. Am J Respir Cell Mol Biol. 2013;49:128\u201334.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1934_CR41","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1165\/rcmb.2014-0027OC","volume":"52","author":"K Waseda","year":"2015","unstructured":"Waseda K, Miyahara N, Taniguchi A, Kurimoto E, Ikeda G, Koga H, et al. Emphysema requires the receptor for advanced glycation end-products triggering on structural cells. Am J Respir Cell Mol Biol. 2015;52:482\u201391.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1934_CR42","doi-asserted-by":"publisher","first-page":"e0180092","DOI":"10.1371\/journal.pone.0180092","volume":"12","author":"L Wolf","year":"2017","unstructured":"Wolf L, Herr C, Niederstra\u00dfer J, Beisswenger C, Bals R. Receptor for advanced glycation endproducts (RAGE) maintains pulmonary structure and regulates the response to cigarette smoke. PLoS ONE. 2017;12:e0180092.","journal-title":"PLoS ONE"},{"key":"1934_CR43","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.acra.2011.01.011","volume":"18","author":"HA Gietema","year":"2011","unstructured":"Gietema HA, M\u00fcller NL, Fauerbach PVN, Sharma S, Edwards LD, Camp PG, et al. Quantifying the extent of emphysema: factors associated with radiologists\u2019 estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol. 2011;18:661\u201371.","journal-title":"Acad Radiol"},{"key":"1934_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.15326\/jcopdf.1.1.2013.0001","volume":"1","author":"SS Kim","year":"2014","unstructured":"Kim SS, Yagihashi K, Stinson DS, Zach JA, McKenzie AS, Curran-Everett D, et al. Visual assessment of CT findings in smokers with nonobstructed spirometric abnormalities in the COPDGene(\u00ae) study. Chronic Obstructive Pulmon Dis (Miami, FLA). 2014;1:88\u201396.","journal-title":"Chronic Obstructive Pulmon Dis (Miami, FLA)"},{"key":"1934_CR45","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1007\/s00330-009-1320-y","volume":"19","author":"E Cavigli","year":"2009","unstructured":"Cavigli E, Camiciottoli G, Diciotti S, Orlandi I, Spinelli C, Meoni E, et al. Whole-lung densitometry versus visual assessment of emphysema. Eur Radiol. 2009;19:1686\u201392.","journal-title":"Eur Radiol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-01934-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-01934-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-01934-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T10:09:11Z","timestamp":1666519751000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-01934-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1934"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-01934-w","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"2 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All clinical procedures were performed according to the standards set by the latest. Declaration of Helsinki. The study was approved by the Institutional Review Board of the National Jewish Health and all participants gave informed written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}